Oxidative Drugs and microRNA: New Opportunities for Cancer Prevention

Cancers (Basel). 2022 Dec 26;15(1):132. doi: 10.3390/cancers15010132.

Abstract

Despite the impressive progress of therapies in recent years, cancer still remains the second leading cause of death in developed countries [...].

Publication types

  • Editorial

Grants and funding

This research was partially funded by the Italian Association for Cancer Research (AIRC), AIRC, grant no. IG-2017 Id.20699.